In Cuba, health officials have approved what’s believed to be the world’s first registered vaccine for lung cancer. Doctors say the treatment, CimaVax EGF, can extend survival rates by an average four to five months, and in some cases longer. The vaccine is said to have few side effects because it attacks only cancer cells.